Special Joint Industry Event

The Fourth Universal Definition of Myocardial Infarction in Conjunction with the Clinical Laboratory Practice Recommendations for the Use of High-Sensitivity Cardiac Troponin in Acute Coronary Syndrome

Wednesday, August 7
7-8:30 a.m.
Hilton Anaheim, Pacific Room C and D

Register for this workshop

This Joint Industry Sponsored Workshop was developed in partnership with AACC and on behalf of Abbott, Beckman Coulter, ET Healthcare Inc., Ortho Clinical Diagnostics, Roche Diagnostics, and Siemens Healthineers.

Please note that registration for this event is separate from registration for the AACC Annual Scientific Meeting. Limited seating available and a complimentary breakfast will be provided.

Session Description

Consensus recommendations with the Fourth Universal Definition of Myocardial Infarction guidelines reinforce guidance on the use of high-sensitivity cardiac troponin assays published by the AACC Academy Laboratory Medicine Practice group and IFCC Committee on Clinical Applications of Biomarkers. This workshop provides cross-discipline (laboratory, emergency medicine, cardiology) commentary with evidence-based rule-out, diagnostic, and risk assessment clinical studies addressing: quality control utilization, reportable analytical limits, units for reporting, sex-specific 99th percentiles, defining high-sensitivity assays, preanalytic/analytic challenges, harmonizing assays, turnaround times, and biological variabilities in interpreting serial (delta) collections.

A multi-disciplinary expert panel will address audience questions.

What You Will Learn

  • Understand the laboratory medicine expert recommendations along with the Fourth Universal Definition of Myocardial Infarction for the use of high-sensitivity cardiac troponin in acute coronary syndromes including impact to emergency medicine, cardiology, and laboratory medicine.
  • Become educated on the analytical characteristics unique to high-sensitivity cardiac troponin assays, how they differ from contemporary and point-of-care assays, and guidance on how to implement high-sensitivity cardiac troponin assays in clinical practice.
  • Explore clinical and analytical challenges encountered in daily practice by the laboratory, emergency medicine, and cardiology following implementation with an interactive expert panel discussion and audience engagement.

Keynote Speakers

Fred S. Apple, PhD, DABCC, FACSM
Medical Director of Clinical Laboratories
Hennepin Country Medical Center
Professor, Laboratory Medicine and Pathology
University of Minnesota School of Medicine
Minneapolis, Minnesota USA

Allan Jaffe, MD
Division of Clinical Core Laboratory Services Chair
Department of Laboratory Medicine and Pathology
Mayo Clinic
Rochester, Minnesota USA

Richard Body, MB ChB, MRCSEd(A&E), FRCEM, PhD
Professor of Emergency Medicine
University of Manchester
Manchester, UK

Peter Kavsak, PhD
Clinical Biochemist
Hamilton Regional Laboratory Medicine Program
Juravinski Hospital and Cancer Centre
Hamilton, Ontario CAN

Panelists

Paul Collinson, MD, PhD
Amy Saenger, PhD, DABCC
Martin Than, MD
Alan Wu, PhD

ACCENT® Accreditation

AACC designates this activity for a maximum of 1.5 ACCENT® credit hours towards the AACC Clinical Chemist’s Recognition Award. AACC is an approved provider of continuing education (CE) for clinical laboratory scientists licensed in states that require documentation of CE, including California, Florida, Louisiana, Montana, Nevada, North Dakota, Rhode Island, Tennessee, and West Virginia. ACCENT® credit is also recognized by several organizations: AAB, ABCC, ACS, AMT, ASCLS, ASCP, ASM, CAP, IFCC, and NRCC.

Supported By


abbott


Beckman Coulter logo


ET Healthcare, Inc logo


ortho clinical diagnostics logo


Roche Diagnostics Logo


siemens logo